Anderson W K, Jones A N
J Med Chem. 1984 Dec;27(12):1559-65. doi: 10.1021/jm00378a006.
A series of bis(hydroxymethyl)-substituted heterocycles were synthesized and converted to the corresponding bis(methylcarbamate) derivatives. The heterocyclic systems studied were based on 2-phenyl-3-methylfuran (2-4), 1-phenylpyrazole (5-7), 1-phenyl-5-methylpyrazole (9-11), 1-phenyl-5-methylthiophene (13), 1-phenyl-1,2,3-triazole (14), 3-phenylisoxazole (15), 3-phenylisothiazole (16), 2-phenylthiazole (17), and 2-phenyloxazole (18). None of the bis(carbamates) prepared was active against murine P388 lymphocytic leukemia. Pyrrole bis(carbamates) 20 and 21, which exhibited antileukemic activity, also showed reactivity toward 4-(p-nitrobenzyl)pyridine while the inactive bis(carbamates) were unreactive in the 4-(p-nitrobenzyl)pyridine assay.
合成了一系列双(羟甲基)取代的杂环化合物,并将其转化为相应的双(甲基氨基甲酸酯)衍生物。所研究的杂环体系基于2-苯基-3-甲基呋喃(2-4)、1-苯基吡唑(5-7)、1-苯基-5-甲基吡唑(9-11)、1-苯基-5-甲基噻吩(13)、1-苯基-1,2,3-三唑(14)、3-苯基异恶唑(15)、3-苯基异噻唑(16)、2-苯基噻唑(17)和2-苯基恶唑(18)。所制备的双(氨基甲酸酯)均对小鼠P388淋巴细胞白血病无活性。具有抗白血病活性的吡咯双(氨基甲酸酯)20和21在4-(对硝基苄基)吡啶检测中也表现出反应活性,而无活性的双(氨基甲酸酯)在该检测中无反应活性。